GLP-1 SMG 10mg

Back to Products

Price: Original price was: CHF 99.00.Current price is: CHF 59.00.

Semaglutide is a synthetic acylated analogue of glucagon-like peptide-1 (GLP-1). Supplied as a reference material for in-vitro GLP-1 receptor research.

FOR LABORATORY RESEARCH ONLYIntended exclusively for in-vitro laboratory research by qualified professionals. Not approved or intended for human or veterinary use, consumption, or therapeutic applications. See our Research Use Disclaimer.

Description

Overview

Semaglutide is a GLP-1(7-37) analogue with an Aib substitution at position 8 and a C18 fatty-diacid side chain on Lys26, which promote albumin binding and resistance to DPP-4.

In the laboratory it is used in GLP-1 receptor activation, cAMP-signalling and albumin-binding assays. No claims are made regarding effects in humans or animals.

Typical in-vitro applications

GLP-1R activation assays (cAMP readout)
Albumin-binding and stability studies
Analytical method development for lipidated peptides

Compound data

Compound: Semaglutide
Compound class: Acylated GLP-1 receptor agonist peptide
Receptor class: GLP-1 receptor
Net content: 10 mg per vial (stated for analytical and preparative calculations)
Purity specification: ≥99% (HPLC); measured value on the lot certificate of analysis
Form: Lyophilised powder
Intended use: In-vitro laboratory research only

Storage & handling

Store the sealed vial at −20 °C, dry and protected from light.
Allow the vial to reach room temperature before opening to avoid condensation.
Handle with standard laboratory protective equipment (gloves, lab coat, eye protection).
Shipped at ambient temperature in insulated, tamper-evident packaging.

Analytical documentation

HPLC purity and LC-MS identity are tested for every lot. Certificates of analysis and third-party test reports are published in our COA library on the About Us page.

For laboratory research use only. Not for human or veterinary use. See our Research Use Disclaimer.